(Q43041371)

12 November 2017

title

Effect of chronic hepatitis C virus infection on inflammatory lipid mediators (English)

1 reference

12 November 2017

1 reference

1 reference

5

1 reference

12 November 2017

9

1 reference

12 November 2017

10

1 reference

12 November 2017

author name string

Cristina Tosti Guerra

1

1 reference

12 November 2017

Patrizio Caini

2

1 reference

12 November 2017

Carlo Giannini

3

1 reference

12 November 2017

Francesca Giannelli

4

1 reference

12 November 2017

Antonio Petrarca

6

1 reference

12 November 2017

Vera Solazzo

7

1 reference

12 November 2017

Monica Monti

8

1 reference

12 November 2017

publication date

1 September 2007

1 reference

Digestive and Liver Disease

12 November 2017

published in

1 reference

12 November 2017

volume

39 Suppl 1

1 reference

12 November 2017

page(s)

S76-82

1 reference

Hepatitis C virus biology

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

Immunopathogenesis of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

Serum level of soluble intercellular adhesion molecule 1 in patients with chronic liver disease related to hepatitis C virus: A prognostic marker for responses to interferon treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

Vascular cell adhesion molecule-1 (VCAM-1) plays a central role in the pathogenesis of severe forms of vasculitis due to hepatitis C-associated mixed cryoglobulinemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

Anti-endothelial cell auto-antibodies in hepatitis C virus mixed cryoglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

Platelet-activating factor acetylhydrolases in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

Role of platelet-activating factor in cardiovascular pathophysiology.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

Binding of human lipoproteins (low, very low, high density lipoproteins) to recombinant envelope proteins of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

Hepatitis C virus particles of different density in the blood of chronically infected immunocompetent and immunodeficient patients: Implications for virus clearance by antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

Association of hepatitis C virus in human sera with beta-lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

Binding of hepatitis C virus to CD81

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

CD81 is an entry coreceptor for hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

Cellular glycosaminoglycans and low density lipoprotein receptor are involved in hepatitis C virus adsorption

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

Low density lipoprotein receptor as a candidate receptor for hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

The interaction of natural hepatitis C virus with human scavenger receptor SR-BI/Cla1 is mediated by ApoB-containing lipoproteins.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

Infection of peripheral mononuclear blood cells by hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

Hepatitis C virus infection of mononuclear cells from peripheral blood and liver infiltrates in chronically infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

The p38 MAPK pathway mediates transcriptional activation of the plasma platelet-activating factor acetylhydrolase gene in macrophages stimulated with lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

Plasma platelet activating factor-acetylhydrolase (PAF-AH).

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

Extrahepatic manifestations of HCV infection: facts and controversies

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

Cell entry of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

Sol Sherry lecture in thrombosis: molecular events in acute inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

Endothelial cell-associated platelet-activating factor: a novel mechanism for signaling intercellular adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

Isoform-dependent cholesterol efflux from macrophages by apolipoprotein E is modulated by cell surface proteoglycans.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

Visualization of hepatitis C virions and putative defective interfering particles isolated from low-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

Platelet-activating factor: a mediator for clinicians

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

PAF acetylhydrolase gene polymorphisms and asthma severity

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

Anti-inflammatory properties of a platelet-activating factor acetylhydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

HDL-associated PAF-AH reduces endothelial adhesiveness in apoE-/- mice

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

Human plasma platelet-activating factor acetylhydrolase binds to all the murine lipoproteins, conferring protection against oxidative stress.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

Reduction in the extent of atherosclerosis in apolipoprotein E-deficient mice induced by electroporation-mediated transfer of the human plasma platelet-activating factor acetylhydrolase gene into skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2807%2980016-8

7 January 2021

10.1016/S1590-8658(07)80016-8

Identifiers

DOI

1 reference

12 November 2017

1 reference